| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
BIO-key Intl (NASDAQ:BKYI) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.12...